Scholarly Index
Joshua D. Rosenblat
University of Toronto; 18,560 total citations; 329 total publications; best world rank #5
University of Toronto
18,560Total citations
329Total publications
70H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Tryptophan and brain disorders | Lifetime | 139 | CA 9 | 99.12 |
| Treatment of Major Depression | Lifetime | 147 | CA 12 | 98.77 |
| Bipolar Disorder and Treatment | Lifetime | 264 | CA 22 | 98.40 |
| Mental Health Research Topics | Lifetime | 935 | CA 47 | 96.02 |
| Psychedelics and Drug Studies | Lifetime | 262 | CA 7 | 92.68 |
| Electroconvulsive Therapy Studies | Lifetime | 579 | CA 40 | 92.03 |
| Tryptophan and brain disorders | 2021-2025 | 6 | CA 2 | 99.74 |
| Treatment of Major Depression | 2021-2025 | 5 | CA 2 | 99.76 |
| Bipolar Disorder and Treatment | 2021-2025 | 38 | CA 5 | 98.15 |
| Chemical synthesis and alkaloids | 2021-2025 | 25 | CA 1 | 97.51 |
| Mental Health Research Topics | 2021-2025 | 162 | CA 6 | 96.65 |
| Neurotransmitter Receptor Influence on Behavior | 2021-2025 | 73 | CA 2 | 95.84 |
| Psychedelics and Drug Studies | 2021-2025 | 50 | CA 2 | 95.90 |
| Stress Responses and Cortisol | 2021-2025 | 719 | CA 28 | 85.43 |
| Electroconvulsive Therapy Studies | 2021-2025 | 248 | CA 19 | 79.50 |
| Alcoholism and Thiamine Deficiency | 2021-2025 | 180 | CA 8 | 68.05 |
| Pharmacovigilance and Adverse Drug Reactions | 2021-2025 | 742 | CA 17 | 55.64 |